ESLAW icon

Estrella Immunopharma, Inc. Warrant
ESLAW

19 hedge funds and large institutions have $2.24M invested in Estrella Immunopharma, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
1
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$1K
Name Market Value Shares Shares
Change
Shares
Change %
BFM
1
Boothbay Fund Management
New York
$2.19M 201,800
ASM
2
ATW SPAC Management
New York
$10.2K 195,000
EFI
3
EHP Funds Inc
Canada
$9.03K 172,315
CH
4
CVI Holdings
Delaware
$4.78K 86,040 -100 -0.1%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$4.35K 78,381 +54,010 +222%
YCM
6
Yakira Capital Management
Connecticut
$3.5K 66,785
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$3.45K 87,500
SIA
8
SkyView Investment Advisors
New Jersey
$3K 62,500
RCM
9
Radcliffe Capital Management
Pennsylvania
$2.62K 50,000
WA
10
Whitebox Advisors
Minnesota
$2.52K 45,476
SOA
11
Sea Otter Advisors
Florida
$2.22K 40,000
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$2.05K 51,929
Citadel Advisors
13
Citadel Advisors
Florida
$2.01K 50,920 +50,920 New
RCM
14
Robinson Capital Management
Michigan
$1.68K 23,610 +11,805 +100%
CS
15
Clear Street
New York
$1.6K 28,891 +1,200 +4%
SSA
16
Schonfeld Strategic Advisors
New York
$1.02K 19,500
LCM
17
Landscape Capital Management
New Jersey
$759 13,682
Bank of America
18
Bank of America
North Carolina
$16 400
UBS Group
19
UBS Group
Switzerland
$8 200 +200 New
KPF
20
K2 Principal Fund
Ontario, Canada
-118,936 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Citigroup
22
Citigroup
New York